Extrawell Pharmaceutical relocates Bermuda registered office to Richmond House, Hamilton HM 08PUBT·Jul 31 at 03:32 AM00858+1.27%
Artini swings to FY26 net loss of HK$9.63 million; revenue rises 7.6% to HK$162.12 millionPUBT·Jun 30 at 08:31 AM007890.00%
Starcoin postpones shareholder meeting on HK$715 million convertible bond restructuring until September 2026PUBT·Jun 30 at 07:25 AM003990.00%00858+1.27%
Extrawell Pharma expects at least HK$950 million loss for FY2026, swings from profitPUBT·Jun 23 at 08:15 AM00858+1.27%003990.00%
Extrawell Pharma Extends Bond Amendment Deadline and Delays Shareholder CircularTip Ranks·May 29 at 10:21 AM00858+1.27%003990.00%
"Performance" EXTRAWELL PHAR reported a mid-term loss of 460 million yuan, turning from profit to lossAASTOCKS·Nov 30, 2025 at 05:52 AM00858+1.27%
EXTRAWELL PHAR completed the placement of a total of 160 million sharesZhitong·Sep 10, 2025 at 04:09 AM00858+1.27%
EXTRAWELL PHAR plans to issue a total of 160 million shares, with net proceeds used for new business developmentZhitong·Aug 14, 2025 at 06:15 PM00858+1.27%
"Performance" EXTRAWELL PHAR achieved a net profit of 223 million yuan for the year, turning losses into profitsAASTOCKS·Jul 1, 2025 at 06:37 AM00858+1.27%
EXTRAWELL PHAR announced its annual performance, with profit attributable to shareholders of approximately HKD 223 million, turning a profit compared to the same period last yearZhitong·Jun 30, 2025 at 10:17 AM00858+1.27%
"Profit Alert" EXTRAWELL PHAR forecasts a turnaround from loss to profit, with annual profit of at least 215 million yuanAASTOCKS·Jun 23, 2025 at 10:52 AM00858+1.27%
EXTRAWELL PHAR issues earnings guidance, expecting annual performance to turn from loss to profit, reaching approximately HKD 215 million to HKD 225 million year-on-yearZhitong·Jun 23, 2025 at 07:32 AM00858+1.27%
